Novel heterocyclic compounds having a structure according to general formula (1), pharmaceutically acceptable acid addition salts and solvates thereof are described as having a pharmacological profile showing potential for treatment of acute and chronic neuropsychiatric disorders which are known as progressively deteriorating conditions leading to neuronal cell death and dysfunction. Pharmaceutical formulations are described as containing said therapeutic compounds.
本发明涉及一种结构符合通式(1)的新型
杂环化合物,其药学上可接受的酸盐和溶剂化物,具有潜在的药理学特性,可用于治疗急性和慢性神经精神障碍,这些障碍是逐渐恶化的状况,导致神经
细胞死亡和功能障碍。本发明还描述了包含该治疗化合物的药物制剂。